Brief: Sesen Bio Got Determination From Nasdaq That Co Granted An Exception From Its Non-Compliance With $1 Bid Price Requirement

Carisma Therapeutics

27/02/2023 13:28

Feb 27 (Reuters) - Sesen Bio Inc  SESN.O :
    * ON FEB 24, GOT DETERMINATION FROM NASDAQ THAT CO GRANTED
AN
EXCEPTION FROM ITS NON-COMPLIANCE WITH $1.00 BID PRICE
REQUIREMENT
    * WAS EXCEPTION FROM NON-COMPLIANCE WITH THE $1.00 BID PRICE
REQUIREMENT TO COMPLETE PROPOSED MERGER WITH CARISMA
THERAPEUTICS INC


Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com))